Injection mcg/vial (Polyclonal) (Thiomersal 273 Injection 300mcg/vial GH CHC PHC IPD Free) 17.3 For specific groups of individuals Tetanus 0.5 ml Sub 166 274 Injection GH CHC PHC IPD vaccine Ampoule centre 1 % vial, 10 Hepatitis B Sub 167 275 Injection mg/ml, 10 GH CHC PHC IPD vaccine centre ml vial 276 Anti Rabies Injection ID 1 ml GH CHC PHC IPD vaccine 168 277 Injection IM 0.5 ml GH CHC PHC IPD Diploid) 18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS Atracurium 169 278 Injection 10 mg/ ml GH OT besylate Succinyl 170 279 Injection 50 mg/ml GH OT Choline Vial 500 mcg/ 171 280 Injection ml in 1 ml GH OT (methyl) amp 19. OPHTHALMOLOGICAL PREPARATIONS 19.1 Anti-infective agents Sub 172 281 Ointment 1% GH CHC PHC OPD centre Sub 282 Drops 0.3% GH CHC PHC OPD 173 centre 283 Ointment 0.3% GH OPD + 174 284 Eye Drops 0.3% +0.1% GH OPD 0.3%w/v, 5 175 285 Tobramycin Eye drops GH OPD ml 0.5%w/v, 5 176 286 Eye drops GH OPD ml 19.3 Anti-inflammatory agents 177 287 Eye drops 1% GH OPD (sodium
Injection (Polyclonal) (Thiomersal Free) mcg/vial 273 Injection 300mcg/vial GH CHC PHC IPD 17.3 For specific groups of individuals 166 274 Tetanus vaccine Injection 0.5 ml Ampoule GH CHC PHC Sub centre IPD 167 275 Hepatitis B vaccine Injection 1 % vial, 10 mg/ml, 10 ml vial GH CHC PHC Sub centre IPD 168 276 Anti Rabies vaccine Diploid) Injection ID 1 ml GH CHC PHC IPD 277 Injection IM 0.5 ml GH CHC PHC IPD 18. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS 169 278 Atracurium besylate Injection 10 mg/ ml GH OT 170 279 Succinyl Choline Vial Injection 50 mg/ml GH OT 171 280 (methyl) Injection 500 mcg/ ml in 1 ml amp GH OT 19. OPHTHALMOLOGICAL PREPARATIONS 19.1 Anti-infective agents 172 281 Ointment 1% GH CHC PHC Sub centre OPD 173 282 Drops 0.3% GH CHC PHC Sub centre OPD 283 Ointment 0.3% GH OPD 174 284 + Eye Drops 0.3% +0.1% GH OPD 175 285 Tobramycin Eye drops 0.3%w/v, 5 ml GH OPD 176 286 Eye drops 0.5%w/v, 5 ml GH OPD 19.3 Anti-inflammatory agents 177 287 (sodium Eye drops 1% GH OPD
Guidelines_for_purchases_under_Consolidated_User_Fee_Fund.docx